Clinical Trials Browser

Carcinoma, Transitional Cell

NCT07489495 2026-03-24

LITESPARK-034

Phase 3 Not yet recruiting

758 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT07480356 2026-03-18

ADVANCED-3

Phase 3 Not yet recruiting

284 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Neoplasms

NCT07464145 2026-03-11

RESCUE

Phase 3 Not yet recruiting

393 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Neoplasms, Urologic Neoplasms

NCT06959433 2026-02-27

Lu-177 PSMA Treatment in Cell Renal Carcinoma

Phase 3 Not yet recruiting

20 enrolled

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT07424287 2026-02-20

A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC

Phase 3 Not yet recruiting

236 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT07383441 2026-02-03

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

Phase 3 Not yet recruiting

718 enrolled

Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT07365995 2026-01-26

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

Phase 3 Not yet recruiting

736 enrolled

Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT07346053 2026-01-16

Chrono-EVP

Phase 3 Not yet recruiting

224 enrolled

Genitourinary

Advanced Bladder Cancer

NCT07338981 2026-01-14

The Impact of Time-of-day-Dependent Administration of Nivolumab-Ipilimumab (ICI/ICI) Combination on Overall Survival in Adults With Advanced Kidney Cancer: A Pragmatic Multicenter, Randomized Controlled Trial.

Phase 3 Not yet recruiting

142 enrolled

Genitourinary

Advanced Kidney Cancer

NCT07333066 2026-01-12

REINFORCE

Phase 3 Not yet recruiting

320 enrolled

Genitourinary

Prostatic Neoplasms

NCT06024772 2025-12-22

Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer

Phase 3 Not yet recruiting

300 enrolled

Genitourinary

Prostatic Neoplasms

NCT07268339 2025-12-05

TRAIN

Phase 3 Not yet recruiting

328 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT07207824 2025-10-06

HERO

Phase 3 Not yet recruiting

182 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Neoplasms

NCT07200830 2025-10-01

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Phase 3 Not yet recruiting

1,524 enrolled

Genitourinary

Prostatic Neoplasms

NCT07165418 2025-09-10

A Comparison of Vorolanib Tablets Combined With Everolimus Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma Who Have Progressed After Treatment With Immunotherapy Monotherapy or in Combination With TKI

Phase 3 Not yet recruiting

116 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT06922903 2025-04-13

Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer.

Phase 3 Not yet recruiting

240 enrolled

Genitourinary

Prostatic Neoplasms

NCT06922929 2025-04-11

A Multicenter, Open-label, Prospective Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Participants With Suspected Recurrent Prostate Cancer After Radical Treatment

Phase 3 Not yet recruiting

110 enrolled

Genitourinary

Prostate Cancer Recurrent

NCT06855589 2025-03-04

PCS-XII

Phase 3 Not yet recruiting

400 enrolled

Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT06364904 2025-02-21

A Clinical Trail to Determine the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Gemcitabine, With or Without Trilaciclib for Patients With Untreated Unresectable and Metastatic Urothelial Carcinoma.

Phase 3 Not yet recruiting

210 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT06837896 2025-02-20

Efficacy and Safety Study of QLG1080 in Patients With Hormone-sensitive Advanced Prostate Cancer

Phase 3 Not yet recruiting

110 enrolled

Genitourinary

Prostatic Neoplasms

NCT06768255 2025-01-10

mCRPC

Phase 3 Not yet recruiting

400 enrolled

Genitourinary

Abiraterone Acetate

NCT06327932 2024-03-25

HIVEC in Patients With Non-Muscle-Invasive Bladder Cancer

Phase 3 Not yet recruiting

320 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT06146777 2023-11-29

Multi-classifier System for Stratifying Stage III Papillary Renal Cell Carcinoma of Receiving Adjuvant Therapy

Phase 3 Not yet recruiting

468 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT05810623 2023-04-12

MINERVA

Phase 3 Not yet recruiting

394 enrolled

Genitourinary

Urinary Bladder Neoplasms, Recurrence

NCT05232578 2022-08-03

ESTABLISH

Phase 3 Not yet recruiting

380 enrolled

Genitourinary

Prostatic Neoplasms

Clinical Trials

SYS6002 vs Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma

LITESPARK-034

ADVANCED-3

RESCUE

Lu-177 PSMA Treatment in Cell Renal Carcinoma

A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

Chrono-EVP

The Impact of Time-of-day-Dependent Administration of Nivolumab-Ipilimumab (ICI/ICI) Combination on Overall Survival in Adults With Advanced Kidney Cancer: A Pragmatic Multicenter, Randomized Controlled Trial.

REINFORCE

Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer

TRAIN

HERO

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

A Comparison of Vorolanib Tablets Combined With Everolimus Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma Who Have Progressed After Treatment With Immunotherapy Monotherapy or in Combination With TKI

Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer.

A Multicenter, Open-label, Prospective Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Participants With Suspected Recurrent Prostate Cancer After Radical Treatment

PCS-XII

A Clinical Trail to Determine the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Gemcitabine, With or Without Trilaciclib for Patients With Untreated Unresectable and Metastatic Urothelial Carcinoma.

Efficacy and Safety Study of QLG1080 in Patients With Hormone-sensitive Advanced Prostate Cancer

mCRPC

HIVEC in Patients With Non-Muscle-Invasive Bladder Cancer

Multi-classifier System for Stratifying Stage III Papillary Renal Cell Carcinoma of Receiving Adjuvant Therapy

MINERVA

ESTABLISH